Fundraising FoxCaaMTech
2 known investors
Find your way into CaaMTech
Sign up to find every way you can get introduced to CaaMTech
- Your email: who you already know at CaaMTech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CaaMTech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
Founders & leadership
Investors · 2
Frequently asked questions
- What does CaaMTech do?
- CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
- Who founded CaaMTech?
- CaaMTech was founded by Andrew Chadeayne.
- Who are CaaMTech's investors?
- CaaMTech's investors include Kortschak Investments L.P., Noetic.